Nutcracker Therapeutics Stock
Nutcracker Therapeutics is a biotechnology company focused on advancing RNA-based treatments through innovative manufacturing technologies. Nutcracker aims to revolutionize the development of RNA therapeutics by leveraging its proprietary platform for mRNA synthesis and formulation.
Sign up for SecondMarket™ to view the market and buy or sell Nutcracker Therapeutics Stock
Buy + SellNutcracker Therapeutics Funding
Sign up to gain insights into Nutcracker Therapeutics funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Aug 27, 2021 | Series C | 144.50M | ||
| May 08, 2020 | Series B | 14.00M | ||
| Mar 11, 2019 | Series A | 10.00M | ||
| Apr 30, 2018 | Series Seed | 4.00M |
See Nutcracker Therapeutics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Nutcracker Therapeutics Stock Valuation + Share Prices
View real-time Tape D™ data on Nutcracker Therapeutics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Nutcracker Therapeutics Management Team
Co-Founder, CEO
Igor Khandros
Director
Michael Bigham
Nutcracker Therapeutics Major Investors
Bluebird Ventures
ARCH Venture Partners
Sutter Hill Ventures
Learn More About Nutcracker Therapeutics Stock
Buy Nutcracker Therapeutics Stock
01Nutcracker Therapeutics stock does not trade on public stock exchanges. Nutcracker Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Nutcracker Therapeutics stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Nutcracker Therapeutics Stock
02Nutcracker Therapeutics Stock does not trade on public stock exchanges. In order to sell Nutcracker Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nutcracker Therapeutics Stock Price
03Nutcracker Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Nutcracker Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
Nutcracker Therapeutics Stock Ticker Symbol
04There is no ticker symbol for Nutcracker Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Nutcracker Therapeutics Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Nutcracker Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Nutcracker Therapeutics Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Nutcracker Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Nutcracker Therapeutics Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Nutcracker Therapeutics IPO
08Nutcracker Therapeutics is a private company and has not had an IPO. There is currently no Nutcracker Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Nutcracker Therapeutics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Nutcracker Therapeutics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
